Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Why are NASA's Artemis astronauts wearing orange? What are they bringing to space? What to know about the preparation for their moon mission. - 2Vote In favor of Feasible Way You Prescribe to Shop for Garments
- 3Interstellar comet 3I/ATLAS to pass closest to Earth on Friday
- 4UK clothing inflation climbs as Middle East turmoil threatens wider price rises
- 5Inside Plan with Houseplants: An Aide
- Most loved Well known Accessory Styles For 2024
- Anthony Joshua's driver charged over Nigeria crash that killed two
- Prehistoric wolf’s gut frozen in time reveals an ice age giant
- Scientists find evidence that an asteroid contains tryptophan
- Change Your Physical make-up: Compelling Activities for Muscle Building
- Figure out How to Pick a Crematorium: Key Contemplations.
- Working out at the airport? Some fliers can already smell the sweat.
- Chicago reports first rabies-positive dog in 61 years. What we know.
- Vote in favor of your Number one kind of juice
